Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway
British Journal of Cancer, Published online: 05 February 2024; doi:10.1038/s41416-024-02599-6Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 5, 2024 Category: Cancer & Oncology Authors: Jun Yang Source Type: research
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus
British Journal of Cancer, Published online: 05 February 2024; doi:10.1038/s41416-024-02583-0Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 5, 2024 Category: Cancer & Oncology Authors: Masashi Hashimoto Shinji Kuroda Nobuhiko Kanaya Daisuke Kadowaki Yusuke Yoshida Masaki Sakamoto Yuki Hamada Ryoma Sugimoto Chiaki Yagi Tomoko Ohtani Kento Kumon Yoshihiko Kakiuchi Kazuya Yasui Satoru Kikuchi Ryuichi Yoshida Hiroshi Tazawa Shunsuke Kagawa Source Type: research
Antibodies toward Na+,HCO3–-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer
British Journal of Cancer, Published online: 03 February 2024; doi:10.1038/s41416-024-02591-0Antibodies toward Na+,HCO3–-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 3, 2024 Category: Cancer & Oncology Authors: Trine V. Axelsen Claus Olesen Danish Khan Ali Mohammadi Elena V. Bouzinova Christine J. F. Nielsen Marco Mele Katrine R. Hauerslev Helene L. Pedersen Eva Balling Pernille Vahl Trine Tramm Peer M. Christiansen Ebbe Boedtkjer Source Type: research
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer
British Journal of Cancer, Published online: 02 February 2024; doi:10.1038/s41416-024-02588-9A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 2, 2024 Category: Cancer & Oncology Authors: Simon Holt Mark Verrill Laura Pettit Anna Rigg Tamas Hickish Caroline Archer Jo Dent Marianne Dillon Mark Nathan Ludger Barthelmes Shazza Rehman Yousef Sharaiha Paige Innis Priya Sai-Giridhar Saira Khawaja Source Type: research
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration
British Journal of Cancer, Published online: 30 January 2024; doi:10.1038/s41416-024-02576-zImmune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 30, 2024 Category: Cancer & Oncology Authors: Masaya Kanahori Eijiro Shimada Yoshihiro Matsumoto Makoto Endo Toshifumi Fujiwara Akira Nabeshima Takeshi Hirose Kengo Kawaguchi Ryunosuke Oyama Yoshinao Oda Yasuharu Nakashima Source Type: research
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours
British Journal of Cancer, Published online: 29 January 2024; doi:10.1038/s41416-023-02436-2A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 29, 2024 Category: Cancer & Oncology Authors: Howard A. Burris Jordan Berlin Tobias Arkenau Gregory M. Cote Martijn P. Lolkema Jordi Ferrer-Playan Anup Kalapur Jayaprakasam Bolleddula Giuseppe Locatelli Thomas Goddemeier Ioannis Gounaris Johann de Bono Source Type: research
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
British Journal of Cancer, Published online: 29 January 2024; doi:10.1038/s41416-024-02584-zInhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 29, 2024 Category: Cancer & Oncology Authors: Esha T. Shah Christopher Molloy Madeline Gough Thomas Kryza Selwin G. Samuel Amos Tucker Maneet Bhatia Genevieve Ferguson Rebecca Heyman Shivam Vora James Monkman Emma Bolderson Arutha Kulasinghe Yaowu He Brian Gabrielli John D. Hooper Derek J. Richard Ke Source Type: research
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma
British Journal of Cancer, Published online: 27 January 2024; doi:10.1038/s41416-024-02579-wIdentification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 27, 2024 Category: Cancer & Oncology Authors: Wanzun Lin Xiaochuan Chen Zongwei Huang Qin Ding Hanxuan Yang Ying Li Duo Lin Jun Lin Haojiong Zhang Xuelian Yang Chao Li Chuanben Chen Sufang Qiu Source Type: research
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib
British Journal of Cancer, Published online: 27 January 2024; doi:10.1038/s41416-024-02580-3Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 27, 2024 Category: Cancer & Oncology Authors: Thomas Gaillard Jeanne Piketty Jean-Guillaume Feron Noemie Girard Lea Pauly Elodie Gauroy Lauren Darrigues Beatriz Grandal Jean-Yves Pierga Anne-Sophie Hamy-Petit Fabien Reyal Enora Laas Source Type: research
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
British Journal of Cancer, Published online: 26 January 2024; doi:10.1038/s41416-023-02570-xAlbendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20 (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 26, 2024 Category: Cancer & Oncology Authors: Iram Fatima Rizwan Ahmad Susmita Barman Saiprasad Gowrikumar Kristina Pravoverov Mark Primeaux Kurt W. Fisher Amar B. Singh Punita Dhawan Source Type: research
Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors
British Journal of Cancer, Published online: 26 January 2024; doi:10.1038/s41416-024-02586-xFarnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 26, 2024 Category: Cancer & Oncology Authors: Marcell Baranyi Eszter Moln ár Luca Heged űs Zs ófia Gábriel Fl óra Gréta Petényi Fanni Bord ás Violetta L éner Ivan Ran đelović Mih ály Cserepes J ózsef Tóvári Bal ázs Hegedűs J ózsef Tímár Source Type: research
Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma
British Journal of Cancer, Published online: 26 January 2024; doi:10.1038/s41416-024-02582-1Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 26, 2024 Category: Cancer & Oncology Authors: Eun Ju Cho Boram Kim Su Jong Yu Suk Kyun Hong YoungRok Choi Nam-Joon Yi Kwang-Woong Lee Kyung-Suk Suh Jung-Hwan Yoon Taesung Park Source Type: research
wMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning
British Journal of Cancer, Published online: 26 January 2024; doi:10.1038/s41416-024-02587-wwMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 26, 2024 Category: Cancer & Oncology Authors: Hongyan Cao Congcong Jia Zhi Li Haitao Yang Ruiling Fang Yanbo Zhang Yuehua Cui Source Type: research
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
British Journal of Cancer, Published online: 25 January 2024; doi:10.1038/s41416-024-02585-yExposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 25, 2024 Category: Cancer & Oncology Authors: Benoit Blanchet Alexandre Xu-Vuilard Anne Jouinot Florent Puisset David Combarel Olivier Huillard F élicien Le Louedec Fabienne Thomas Marcus Teixeira Ronan Flippot Loic Mourey Laurence Albiges Thomas Pudlarz Charlotte Joly Christophe Tournigand Jonathan Source Type: research
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer
British Journal of Cancer, Published online: 24 January 2024; doi:10.1038/s41416-023-02559-6Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 24, 2024 Category: Cancer & Oncology Authors: Jun Wang Na Sun Thomas Kunzke Jian Shen Annette Feuchtinger Qian Wang Raphael Meixner Ronan Le Gleut Ivonne Haffner Birgit Luber Florian Lordick Axel Walch Source Type: research
